The O6-methyguanine-DNA methyltransferase inhibitor O6-benzylguanine enhanced activity of temozolomide + irinotecan against models of high-risk neuroblastoma.

Hindle, Ashly; Koneru, Balakrishna; Makena, Monish Ram; Lopez-Barcons, Lluis; Chen, Wan Hsi; Nguyen, Thinh H; Reynolds, C Patrick

Hindle, Ashly; Koneru, Balakrishna; Makena, Monish Ram; Lopez-Barcons, Lluis; Chen, Wan Hsi; Nguyen, Thinh H; Reynolds, C Patrick.

Affiliation

Hindle A; Cancer Center, School of Medicine, Texas Tech University Health Sciences Center.
Koneru B; Department of Cell Biology & Biochemistry, Texas Tech University Health Sciences Center.
Makena MR; Departments of Internal Medicine.
Lopez-Barcons L; Cancer Center, School of Medicine, Texas Tech University Health Sciences Center.
Chen WH; Department of Cell Biology & Biochemistry, Texas Tech University Health Sciences Center.
Nguyen TH; Pediatrics, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, Texas.
Reynolds CP; Cancer Center, School of Medicine, Texas Tech University Health Sciences Center.

Anticancer Drugs ; 32(3): 233-247, 2021 03 01.

Article de En | MEDLINE | ID: mdl-33323683

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: O(6)-methylguanine-DNA methyltransferase / Irinotécan / Témozolomide / Guanine / Antinéoplasiques Type d'étude: Etiology_studies / Risk_factors_studies Limites: Animals / Humans Langue: En Journal: Anticancer Drugs Sujet du journal: ANTINEOPLASICOS Année: 2021 Type de document: Article

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google